Quadrivalent Influenza Vaccine(Janssen Research & Development Llc)

N/A

Report date: 2024/07/23 15:58:23

Base Information

Drug NameQuadrivalent Influenza Vaccine(Janssen Research & Development Llc)

Drug Alias NameHD quadrivalent influenza vaccine(Janssen Research & Development Llc)HD QIVHigh-dose quadrivalent seasonal influenza vaccine(Janssen Research & Development Llc)

ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsEscherichia coli Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgiumCanadaUnited States +[4]

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesJanssen Research & Development Llc

China Registration ClassN/A

Develop Information

Active CompaniesJanssen Research & Development Llc

Inactive CompaniesN/A

Active IndicationsEscherichia coli Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A